
Aphria Inc. APHA
Aphria Inc. Gesamtverbindlichkeiten 2011-2026 | APHA
Gesamtverbindlichkeiten Jährlich Aphria Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 660 M | 708 M | 140 M | 42.1 M | 1.27 M | 947 K | 30 K | 11 K | 11 K | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 708 M | 11 K | 173 M |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.98 B | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
28.4 M | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
395 M | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
147 M | $ 16.45 | 0.43 % | $ 3.92 B | ||
|
AgeX Therapeutics
AGE
|
6.61 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
62.5 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
37.2 M | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
390 M | $ 3.64 | -1.89 % | $ 1.09 B | ||
|
I-Mab
IMAB
|
707 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.45 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
20.4 M | - | -13.47 % | $ 169 M | ||
|
Aptorum Group Limited
APM
|
4.35 M | $ 0.83 | 4.23 % | $ 4.53 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.16 M | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
6.46 M | - | -18.52 % | $ 27.3 M | ||
|
Akero Therapeutics
AKRO
|
75.8 M | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
45.1 M | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
107 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Burford Capital Limited
BUR
|
1.45 B | $ 8.4 | -1.81 % | $ 1.39 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
855 M | $ 76.75 | 0.85 % | $ 1.48 B | ||
|
Apellis Pharmaceuticals
APLS
|
705 M | $ 19.93 | -1.14 % | $ 2.51 B | ||
|
Applied Therapeutics
APLT
|
72 M | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
51.5 M | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
109 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.1 B | - | - | - | ||
|
Athersys
ATHX
|
28.4 M | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
13.8 M | - | 1052.0 % | $ 415 M | ||
|
AVEO Pharmaceuticals
AVEO
|
59.5 M | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
602 M | $ 163.82 | -0.14 % | $ 8.15 B | ||
|
BridgeBio Pharma
BBIO
|
3.01 B | $ 66.98 | 3.8 % | $ 12.8 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
9.6 M | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
137 M | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
5.38 M | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
3.83 B | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
84 M | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
470 M | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
21.9 M | - | 5.93 % | $ 314 M | ||
|
Bellerophon Therapeutics
BLPH
|
5.4 M | - | -74.18 % | $ 955 K | ||
|
BioLineRx Ltd.
BLRX
|
25.4 M | $ 2.88 | 2.51 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
1.51 B | $ 60.75 | 3.79 % | $ 11.7 B | ||
|
AIkido Pharma
AIKI
|
7.27 M | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
387 M | $ 3.24 | 1.73 % | $ 1.16 M | ||
|
Cabaletta Bio
CABA
|
17.5 M | $ 3.41 | 4.77 % | $ 3.98 M | ||
|
Ayala Pharmaceuticals
AYLA
|
7.43 M | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
36.1 M | $ 25.71 | -0.5 % | $ 688 M | ||
|
Agios Pharmaceuticals
AGIO
|
104 M | $ 28.49 | 0.04 % | $ 1.65 B | ||
|
CymaBay Therapeutics
CBAY
|
142 M | - | - | $ 3.45 B | ||
|
Avid Bioservices
CDMO
|
276 M | - | - | $ 789 M |